Finland· FI-REL-REL43530
Mifegyne
A mifepristone product containing mifepristone, registered in Finland by Paranova Oy. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Mifepristone is registered in 14 of 19 countries.
Countries holding a registration under ATC G03XB01 (mifepristone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Mifepristone · ATC G03XB01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mifepristone costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mifepristone · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$53.60
The record
At a glance
Fimea (Finland)- Active substance
- Mifepristone
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- G03XB01
- ATC class
- Mifepristone
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for mifepristone.
Graded by severity as the source publishes them — 209 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mifepristone · interactions on record
378 records
- 209 severe
- 161 moderate
- 8 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mifepristone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMifegyne 200 mg, tablettenEuro Registratie Collectief B.V.
- CzechiaMIFEGYNEExelgyn, Paris
- United StatesMifepristoneEvita Solutions LLC
- United KingdomMifegyne 200mg tabletsNordic Pharma Ltd
- SwedenMifegyne 200 mg TablettExelgyn, Paris
- SpainMIFEGYNE 200 mg COMPRIMIDOSExelgyn
- IrelandMifegyne 200 mg tabletsEXELGYN
- FranceMIFEGYNE 200 mg, compriméEXELGYN
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mifegyne
- Belgium · Mifegyne
- Bulgaria · Мифегин
- Cyprus · Mifegyne
- Czechia · Mifegyne
- Germany · Mifegyne
- Denmark · Mifegyne
- Estonia · Mifegyne
- Spain · Mifegyne
- France · Mifegyne, Miffee
- United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
- Greece · Mifegyne
- Croatia · Mifegyne
- Ireland · Mifegyne
- Iceland · Mifegyne
- Italy · Mifegyne
- Lithuania · Mifegyne
- Luxembourg · Mifegyne
- Latvia · Mifegyne
- Netherlands · Mifegyne
- Norway · Mifegyne
- Portugal · Mifegyne
- Romania · Mifegyne
- Sweden · Mifegyne, Mifepristone Nordic
- Slovenia · Mifegyne
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12f1fc1a-50fa-4d01-b1f4-1a0a01163eb6 GET /v1/drugs/12f1fc1a-50fa-4d01-b1f4-1a0a01163eb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.2",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "mifepristoni",
"ma_number": "31455",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL43530",
"authorised_at": "2013-10-10"
}See everything about mifepristone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.